Results 171 to 180 of about 2,358,784 (358)

Remotely controlled drug release in deep brain regions of non-human primates

open access: hybrid
M.G.F. Wilson   +3 more
openalex   +1 more source

Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Aldehyde dehydrogenase 1A1 (ALDH1A1) is a cancer stem cell marker in several malignancies. We established a novel epithelial cell line from rectal adenocarcinoma with unique overexpression of this enzyme. Genetic attenuation of ALDH1A1 led to increased invasive capacity and metastatic potential, the inhibition of proliferation activity, and ultimately ...
Martina Poturnajova   +25 more
wiley   +1 more source

Development and Evaluation of Multiple-Unit Tablets for the Controlled Release of Lornoxicam. [PDF]

open access: yesDrugs R D
Liu Y   +7 more
europepmc   +1 more source

Morphine: immediate release vs. controlled release.

open access: yesNorth Carolina medical journal, 1989
One must ever focus, in the oncology patient, on the possible treatable etiologies of pain which might be amenable to radiotherapy, chemotherapy or surgery. The first goal is to accurately diagnose the source of the pain and then, only if other active intervention is unhelpful, administer analgesic therapy.
openaire   +1 more source

Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation

open access: yesMolecular Oncology, EarlyView.
Dimethyl fumarate (DMF) reduces growth of HPV‐positive cervical cancer spheroids and induces ferroptosis in cervical cancer cells via blocking SLC7A11/Glutathione (GSH) axis. Combination of subcytotoxic doses of DMF and cisplatin (CDDP) further suppresses spheroid growth and drives cell death in 2D culture models.
Carolina Punziano   +6 more
wiley   +1 more source

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra   +6 more
wiley   +1 more source

Controlled release of berberine modulates the wound microbiome to accelerate wound healing. [PDF]

open access: yesAsian J Pharm Sci
Xu Z   +10 more
europepmc   +1 more source

Multifunctional DNA hydrogels with light-triggered gas-therapy and controlled G-Exos release for infected wound healing

open access: gold
Yuyun Ye   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy